Palaiseau, France

François Francou


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: François Francou: Innovator in Nucleic Acid Technology

Introduction

François Francou is a notable inventor based in Palaiseau, France. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acids. His innovative work has implications for therapeutic developments and novel compound synthesis.

Latest Patents

François Francou holds a patent for a method for obtaining nucleic acids from an environmental sample. This method results in nucleic acids that can be utilized in the synthesis of novel compounds. The invention focuses on preparing a library of nucleic acids from a sample, which can be used for various applications, especially in therapeutic contexts. The patent also includes novel vectors and processes for preparing these vectors or recombinant host cells containing the nucleic acids. Additionally, it outlines methods for detecting specific nucleic acids within the resulting library.

Career Highlights

François Francou is associated with Aventis Pharma S.A., where he has been able to apply his expertise in biotechnology. His work has contributed to advancements in the understanding and application of nucleic acids in therapeutic settings.

Collaborations

Some of his notable coworkers include Pascale Jeannin and Jean-Luc Pernodet. Their collaborative efforts have likely enhanced the research and development processes within their projects.

Conclusion

François Francou's contributions to nucleic acid technology exemplify the innovative spirit in biotechnology. His patent reflects a significant advancement that could lead to new therapeutic compounds and methods. His work continues to influence the field and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…